Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM229B pseudogene 1 (TMEM229BP1) is a human pseudogene, meaning it consists of DNA with high sequence similarity to the protein-coding TMEM229B gene but carries mutations or truncations that render it nonfunctional and incapable of producing a protein. Pseudogenes can occasionally act as regulators of gene expression—such as by acting as microRNA decoys or modulators of their parent genes' mRNA levels—but there is no evidence in the scientific literature that TMEM229BP1 plays such a role. TMEM229BP1 is not a receptor, enzyme, transporter, nor described as a therapeutic target in any database or published study. Its primary importance is for genetic annotation; it is not a functional protein, drug target, nor implicated as a biomarker or disease gene. Pseudogenes in general can sometimes act as regulators (regulatory RNAs, miRNA 'sponges'), but these are exceptions, and there is no evidence for TMEM229BP1 specifically. They commonly arise as evolutionary remnants of once-functional genes but are now considered molecular fossils. TMEM229BP1 is not listed among functional targets or disease-associated loci in major databases, and no drugs, mechanisms, clinical roles, or safety concerns are described for it. If you are seeking information about a functional protein or therapeutic target related to TMEM229B, you should instead refer to the TMEM229B gene or protein, not the pseudogene form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMEM229B pseudogene 1 (TMEM229BP1).